BridgeMD
New treatment option for Central Nervous System Cancer
Official title Short Course Radiotherapy
ClinicalTrials.gov ID: NCT07147179
What this study is testing
- What it's testing
- This is a single arm prospective pilot trial determining the safety of short-course radiation therapy in pediatric patients with incurable central nervous system malignancies.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages up to 21
You may be able to join if
- Male or female, aged 21 years or below
- Lansky performance status \>= 40
- Has a diagnosis of an incurable malignancy that:
- Originates outside the brain but is metastatic to 1 or more sites within the brain, or originates and recurs within the brain. For this diagnosis to...
- Has at least 1 targetable intracranial lesion as seen on imaging
You likely can't join if
- Radiotherapy for curative intent
- Serious uncontrolled systemic or psychiatric disorders that would interfere with participation in the protocol
- Being planned for proton radiation
See the full eligibility criteria
- Male or female, aged 21 years or below
- Lansky performance status \>= 40
- Has a diagnosis of an incurable malignancy that:
- Originates outside the brain but is metastatic to 1 or more sites within the brain, or originates and recurs within the brain. For this diagnosis to be confirmed, there must be multidisciplinary review of up to date...
- Has at least 1 targetable intracranial lesion as seen on imaging
- Has a multidisciplinary consensus recommendation for palliative intent radiation
- Consents to the study or has caregiver who is able to provide signed and dated informed consent. For people under the age of 18, a signed and dated assent form as able.
- Patients who had prior radiation in planned treatment area are also eligible to enter the trial
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Radiotherapy for curative intent
- Serious uncontrolled systemic or psychiatric disorders that would interfere with participation in the protocol
- Being planned for proton radiation
The study team makes the final eligibility decision.
Where it's taking place
- Philadelphia, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, up to 21 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.